Anteris Technologies Global (AVR) Other Accumulated Expenses (2024 - 2025)
Anteris Technologies Global (AVR) posted quarterly Other Accumulated Expenses of $211000.0 for Q4 2025, up 145.35% year-over-year from $86000.0 in Q4 2024, and down 54.72% quarter-over-quarter from $466000.0 in Q3 2025.
Anteris Technologies Global (AVR) Other Accumulated Expenses (2024 - 2025) Analysis & Trends
Anteris Technologies Global (AVR) has reported Other Accumulated Expenses for 2 consecutive years, with $211000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Accumulated Expenses rose 145.35% year-over-year to $211000.0; the TTM figure through Dec 2025 stood at $211000.0 (up 145.35% YoY), while the FY2025 annual figure was $211000.0, up 145.35% from the prior year.
- Other Accumulated Expenses retreated to $211000.0 in Q4 2025 per AVR's latest filing, from $466000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $522000.0 in Q2 2025 and bottomed at $86000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Anteris Technologies Global | 875.09 Mn | 875.09 Mn | 776,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 211,000.00 |
| Sep 30, 2025 | 466,000.00 |
| Jun 30, 2025 | 522,000.00 |
| Mar 31, 2025 | 210,000.00 |
| Dec 31, 2024 | 86,000.00 |